CD39L4 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61852r |
| Product Name | CD39L4 Recombinant Antibody |
| Applications |
WB
IP
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human ENTPD5 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 957 |
| Swiss Prot | O75356 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | CD39L4; Entpd5; mNTPase; NTPDase 5; PCPH; UDPase ENTPD5. |
| Background | In the lumen of the endoplasmic reticulum, hydrolyzes UDP that acts as an end-product feedback inhibitor of the UDP-Glc:glycoprotein glucosyltransferases. UMP can be transported back by an UDP-sugar antiporter to the cytosol where it is consumed to regenerate UDP-glucose. Therefore, it positively regulates protein reglucosylation by clearing UDP from the ER lumen and by promoting the regeneration of UDP-glucose. Protein reglucosylation is essential to proper glycoprotein folding and quality control in the ER. |
| Application Dilution | |
| WB | 1:1000-2000 |
| IP | IP1:20-50 |